OnKure Therapeutics, Inc. OKUR Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from OnKure Therapeutics, Inc.’s reported figures.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s free cash flow?
- OnKure Therapeutics, Inc. (OKUR) reported free cash flow of -$12.94M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s free cash flow changed year-over-year?
- OnKure Therapeutics, Inc.'s free cash flow increased by 7.7% year-over-year, from -$14.02M to -$12.94M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s free cash flow?
- Over 3 years (2021 to 2025), OnKure Therapeutics, Inc.'s free cash flow has grown at a 10.8% compound annual growth rate (CAGR), from -$38.18M to -$51.87M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.